Article Text

PDF
Decreased expression of pSTAT, IRF-1 and DAP10 signalling molecules in peripheral blood lymphocytes of patients with metastatic melanoma
  1. Katarina Mirjačić Martinović1,
  2. Tatjana Srdić-Rajić1,
  3. Nada Babović2,
  4. Radan Džodić3,4,
  5. Vladimir Jurišić5,
  6. Gordana Konjević1,4
  1. 1Department of Experimental Oncology, Institute of Oncology and Radiology of Serbia, Belgrade, Serbia
  2. 2Department of Medical Oncology, Institute of Oncology and Radiology of Serbia, Belgrade, Serbia
  3. 3Surgical Oncology Clinic, Institute of Oncology and Radiology of Serbia, Belgrade, Serbia
  4. 4School of Medicine, University of Belgrade, Belgrade, Serbia
  5. 5Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
  1. Correspondence to Professor Vladimir Jurišić, Faculty of Medical Sciences, University of Kragujevac, P.Box 124, Kragujevac 34 000, Serbia; vdvd{at}lycos.com

Abstract

Aims As numerous signalling molecules regulate effector functions of peripheral blood lymphocytes (PBLs) that have an important anti-tumour activity, the aim of this study was to analyse their level in patients with metastatic melanoma (MM) compared with healthy controls (HCs).

Methods Peripheral blood mononuclear cells (PBMCs) of 36 MMs and 28 HCs were analysed for the level of perforin, interferon-regulating transcription factor-1 (IRF-1), DAP10 and Src homology 2 domain-containing tyrosine phosphatase-1 by reverse transcriptase PCR, level of phosphorylated signal transducers and activators of transcription (pSTAT)-1, pSTAT-4, pSTAT-5 by western blot and interferon (IFN)-γ production by ELISA. The expression of activating NKG2D and inhibitory killer immunoglobulin-like receptors (KIR), CD158a and CD158b, on PBL, CD3−CD56+ natural killer (NK) cells and CD3+CD8+ cytotoxic T lymphocytes (CTLs), as well as the percentage of CD14+HLA-DR- cells in PBMC were estimated by flow cytometry.

Results Patients with MM, compared with HCs, had significantly lower level of cytotoxic molecule perforin and decreased IFN-γ production, as well as lower level of pSTAT-1, pSTAT-4, pSTAT-5 and IRF-1 signalling molecules in PBMC. Furthermore, MM had decreased expression of activating NKG2D receptor on PBL and NK cells and low level of its DAP10 signalling molecule contrary to no changes in KIR expression on all investigated cells. These results could be associated with increased percentage of immunosuppressive CD14+HLA-DR− myeloid-derived suppressor cells detected in patients with MM.

Conclusions The altered signalling molecules of PBL could represent biomarkers of impaired cytotoxic and immunoregulatory function of these cells, indicating melanoma-associated immunosuppression that facilitates tumour progression.

  • CELL CYCLE REGULATION
  • IMMUNOPHENOTYPING
  • MELANOMA

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.